Ftse Mib
34.315,24
0,00%
DAX
20.246,37
-0,33%
S&P 500
6.050,61
-0,39%
NASDAQ
20.109,06
-0,32%
Bitcoin
103.893,87
-2,13%
Pepperstone
Advertisement
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Karyopharm Therapeutics Inc (KPTI) Karyopharm Therapeutics Inc (KPTI) Notizie

Karyopharm Therapeutics Inc

KPTI
0,673
0,003 (0,45%)
18 Dic 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
16/12/202422:00EDGAR2Form DEF 14A - Other definitive proxy statements
09/12/202414:00PRNUSKaryopharm Announces the Appointment of Brendan Strong as..
05/12/202422:35EDGAR2Form PRE 14A - Other preliminary proxy statements
05/12/202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/12/202413:09EDGAR2Form 8-K - Current report
03/12/202413:00PRNUSKaryopharm Therapeutics Provides Endometrial Cancer Program..
02/12/202413:00PRNUSKaryopharm Therapeutics Reports Inducement Grants Under..
25/11/202413:00PRNUSKaryopharm to Participate at the Piper Sandler 36th Annual..
22/11/202422:01EDGAR2Form 3 - Initial statement of beneficial ownership of..
20/11/202422:11EDGAR2Form 8-K - Current report
20/11/202422:05PRNUSKaryopharm Therapeutics Announces the Appointment of Chief..
14/11/202422:22EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
08/11/202422:05EDGAR2Form 8-K - Current report
06/11/202422:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/11/202414:02EDGAR2Form S-8 - Securities to be offered to employees in employee..
05/11/202413:47EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
05/11/202413:41EDGAR2Form 8-K - Current report
05/11/202413:30PRNUSKaryopharm Reports Third Quarter 2024 Financial Results and..
01/11/202421:05PRNUSKaryopharm Therapeutics Reports Inducement Grants Under..
31/10/202413:00PRNUSKaryopharm to Report Third Quarter 2024 Financial Results on..
31/10/202412:41EDGAR2Form 8-K - Current report
31/10/202412:30PRNUSKaryopharm Announces Favorable Change in Co-Primary Endpoint..
30/10/202421:30PRNUSKaryopharm to Host Investor Event with Leading Myelofibrosis..
01/10/202422:05PRNUSKaryopharm Therapeutics Reports Inducement Grants Under..
17/9/202422:10EDGAR2Form 8-K - Current report
05/9/202422:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/9/202422:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/9/202422:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/9/202422:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/9/202422:05PRNUSKaryopharm Therapeutics Reports Inducement Grants Under..
03/9/202413:00PRNUSKaryopharm to Participate at Upcoming Investor Conferences
29/8/202422:05EDGAR2Form 8-K - Current report
08/8/202422:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/8/202413:42EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/8/202413:33EDGAR2Form 8-K - Current report
06/8/202413:30PRNUSKaryopharm Reports Second Quarter 2024 Financial Results and..
01/8/202422:05PRNUSKaryopharm Therapeutics Reports Inducement Grants Under..
31/7/202422:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/7/202422:05PRNUSKaryopharm to Report Second Quarter 2024 Financial Results..
19/7/202422:07EDGAR2Form SC TO-I/A - Tender offer statement by Issuer: [Amend]
09/7/202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/7/202422:05PRNUSKaryopharm Therapeutics Reports Inducement Grants Under..
20/6/202414:01EDGAR2Form SC TO-I - Tender offer statement by Issuer
10/6/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
06/6/202422:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/6/202422:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/6/202422:05PRNUSKaryopharm Therapeutics Reports Inducement Grants Under..
01/6/202419:45PRNUSKaryopharm Presents Updated Exploratory Subgroup Analyses..
31/5/202414:00EDGAR2Form 8-K - Current report
30/5/202423:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
Apertura: 0,66 Min: 0,65 Max: 0,6965
Chiusura: 0,67

La tua Cronologia

NASDAQ
KPTI
Karyopharm Therapeutics
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network